Predictive Biosciences to Present at Key Scientific Conferences
Predictive Biosciences, an innovative developer of molecular diagnostic tests, today announced the company will present data on the latest developments related to its CertNDxTM Bladder Cancer Assays at two upcoming scientific conferences, the Molecular Med Tri-Con 2013 and ASCO’s 2013 Genitourinary Cancers Symposium.